Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Wall Street
Price Targets
Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
is 27.44 CNY
with a low forecast of 20 CNY and a high forecast of 35.7 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's stock price target?
Price Target
27.44
CNY
According to Wall Street analysts, the average 1-year price target for
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
is 27.44 CNY
with a low forecast of 20 CNY and a high forecast of 35.7 CNY.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is
22%.
The projected
CAGR
for the next 3 years is
6%.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Operating Income forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is
27%.
The projected
CAGR
for the next 3 years is
11%.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Net Income forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is
19%.
The projected
CAGR
for the next 3 years is
16%.
